YI revenueFY2025CN¥12.56B
- FY YoY
- -12.8%
- 5Y CAGR
- +8.9%
YI revenue was CN¥12.56B for fiscal 2025 (ended Dec 31, 2025), down 12.8% from fiscal 2024. Compound annual growth was +8.9% over 5 years. It rose in 7 of the last 9 fiscal years.
Financials · YI
For fiscal 2025 (ended Dec 31, 2025), 111 Inc. reported CN¥12.56B of revenue and -CN¥66.39M of net income. Figures are in CNY, the currency of its SEC filings.
YI revenue was CN¥12.56B for fiscal 2025 (ended Dec 31, 2025), down 12.8% from fiscal 2024. Compound annual growth was +8.9% over 5 years. It rose in 7 of the last 9 fiscal years.
YI net income was -CN¥66.39M for fiscal 2025 (ended Dec 31, 2025), compared with -CN¥64.74M in fiscal 2024.
YI diluted EPS was -CN¥0.38 for fiscal 2025 (ended Dec 31, 2025), compared with -CN¥0.38 in fiscal 2024.
YI free cash flow was CN¥114.69M for fiscal 2025 (ended Dec 31, 2025), down 53.7% from fiscal 2024.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥12.56B | CN¥14.40B | CN¥14.95B | CN¥13.52B | CN¥12.43B | CN¥8.20B | CN¥3.95B | CN¥1.79B | CN¥959.49M | CN¥873.84M |
| Cost of revenue | CN¥11.83B | CN¥13.57B | CN¥14.10B | CN¥12.68B | CN¥11.80B | CN¥7.84B | CN¥3.79B | CN¥73.93M | CN¥55.88M | - |
| Gross profit | CN¥723.41M | CN¥829.23M | CN¥848.98M | CN¥839.98M | CN¥621.10M | CN¥365.83M | CN¥165.18M | CN¥104.27M | CN¥80.50M | CN¥74.13M |
| Selling, general and admin | CN¥69.46M | CN¥70.91M | CN¥224.20M | CN¥205.62M | CN¥206.98M | CN¥128.23M | CN¥123.50M | CN¥98.76M | CN¥53.43M | CN¥60.84M |
| Operating income | -CN¥2.38M | CN¥2.11M | -CN¥350.10M | -CN¥371.00M | -CN¥642.14M | -CN¥473.31M | -CN¥493.51M | -CN¥400.38M | -CN¥254.02M | -CN¥364.28M |
| Interest expense | CN¥35.57M | CN¥28.33M | CN¥20.14M | CN¥13.44M | CN¥5.49M | CN¥8.82M | CN¥3.62M | - | CN¥55.0K | CN¥751.0K |
| Pre-tax income | -CN¥22.50M | -CN¥20.68M | -CN¥353.18M | -CN¥376.07M | -CN¥621.02M | -CN¥467.11M | -CN¥501.83M | -CN¥382.03M | -CN¥249.33M | -CN¥363.45M |
| Income tax | CN¥13.0K | CN¥96.0K | CN¥251.0K | CN¥0 | CN¥0 | CN¥0 | CN¥0 | CN¥8.0K | - | - |
| Net income | -CN¥66.39M | -CN¥64.74M | -CN¥392.69M | -CN¥416.88M | -CN¥669.81M | -CN¥456.53M | -CN¥499.61M | -CN¥380.09M | -CN¥248.58M | -CN¥363.45M |
| EPS, basic | -CN¥0.38 | -CN¥0.38 | -CN¥2.33 | -CN¥2.50 | -CN¥4.04 | -CN¥2.77 | -CN¥3.05 | -CN¥3.82 | -CN¥3.45 | -CN¥5.81 |
| EPS, diluted | -CN¥0.38 | -CN¥0.38 | -CN¥2.33 | -CN¥2.50 | -CN¥4.04 | -CN¥2.77 | -CN¥3.05 | -CN¥3.82 | -CN¥3.45 | -CN¥5.81 |
| Diluted shares | 174.0M | 171.8M | 168.6M | 166.6M | 165.9M | 164.8M | 163.7M | 99.5M | 72.0M | 72.0M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | CN¥510.97M | CN¥462.29M | CN¥603.52M | CN¥716.79M | CN¥760.67M | CN¥1.32B | CN¥697.72M | CN¥853.74M | CN¥167.66M | CN¥373.50M |
| Receivables | CN¥259.69M | CN¥413.10M | CN¥536.82M | CN¥488.88M | CN¥404.47M | CN¥163.09M | CN¥65.25M | CN¥28.57M | CN¥20.40M | CN¥28.39M |
| Inventory | CN¥998.47M | CN¥1.39B | CN¥1.42B | CN¥1.50B | CN¥1.12B | CN¥766.53M | CN¥486.27M | CN¥210.84M | CN¥144.06M | - |
| Current assets | CN¥2.12B | CN¥2.65B | CN¥2.93B | CN¥3.24B | CN¥2.80B | CN¥2.87B | CN¥1.48B | CN¥1.51B | CN¥730.47M | - |
| Total assets | CN¥2.20B | CN¥2.79B | CN¥3.09B | CN¥3.47B | CN¥3.15B | CN¥3.03B | CN¥1.61B | CN¥1.55B | CN¥763.38M | - |
| Current liabilities | CN¥1.95B | CN¥2.34B | CN¥2.75B | CN¥2.73B | CN¥2.13B | CN¥1.63B | CN¥773.42M | CN¥314.52M | CN¥201.16M | - |
| Short-term debt | CN¥187.63M | CN¥160.98M | CN¥338.07M | CN¥178.99M | CN¥259.66M | CN¥229.25M | CN¥95.08M | - | - | - |
| Total liabilities | CN¥1.99B | CN¥2.41B | CN¥2.81B | CN¥2.83B | CN¥2.30B | CN¥1.70B | CN¥836.37M | CN¥322.65M | CN¥201.16M | - |
| Shareholders' equity | -CN¥702.23M | -CN¥642.64M | -CN¥594.72M | -CN¥408.70M | -CN¥152.15M | CN¥406.40M | CN¥773.92M | CN¥1.22B | -CN¥944.70M | -CN¥688.00M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | CN¥119.14M | CN¥263.02M | -CN¥447.24M | -CN¥23.15M | -CN¥688.84M | -CN¥116.78M | -CN¥512.38M | -CN¥343.02M | -CN¥204.37M | -CN¥388.65M |
| Capital expenditures | CN¥4.45M | CN¥15.20M | CN¥9.82M | CN¥31.57M | CN¥62.59M | CN¥25.50M | CN¥20.03M | CN¥14.44M | CN¥6.80M | CN¥5.35M |
| Free cash flow | CN¥114.69M | CN¥247.82M | -CN¥457.07M | -CN¥54.73M | -CN¥751.43M | -CN¥142.28M | -CN¥532.41M | -CN¥357.46M | -CN¥211.17M | -CN¥393.99M |
| Investing cash flow | -CN¥53.72M | CN¥37.38M | CN¥151.74M | -CN¥47.17M | CN¥60.14M | -CN¥324.67M | CN¥237.68M | CN¥44.45M | -CN¥36.13M | -CN¥267.55M |
| Financing cash flow | -CN¥21.19M | -CN¥406.24M | CN¥205.98M | CN¥22.73M | CN¥74.34M | CN¥1.07B | CN¥108.99M | CN¥972.70M | CN¥49.50M | CN¥148.42M |
| Share repurchases | - | - | - | - | CN¥5.89M | CN¥11.98M | CN¥22.99M | - | - | - |
| Stock-based compensation | CN¥10.05M | CN¥20.15M | CN¥226.69M | CN¥162.07M | CN¥145.59M | CN¥75.69M | CN¥54.28M | CN¥51.36M | CN¥9.92M | CN¥3.44M |
| Depreciation and amortization | CN¥11.84M | CN¥16.97M | CN¥21.78M | CN¥40.82M | CN¥27.22M | CN¥14.02M | CN¥11.67M | CN¥11.27M | CN¥14.82M | CN¥12.06M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -12.8% | -3.7% | 10.6% | 8.8% | 51.5% | 107.6% | 121.3% | 86.1% | 9.8% | - |
| Gross margin | 5.8% | 5.8% | 5.7% | 6.2% | 5.0% | 4.5% | 4.2% | 5.8% | 8.4% | 8.5% |
| Operating margin | -0.0% | 0.0% | -2.3% | -2.7% | -5.2% | -5.8% | -12.5% | -22.4% | -26.5% | -41.7% |
| Net margin | -0.5% | -0.4% | -2.6% | -3.1% | -5.4% | -5.6% | -12.6% | -21.3% | -25.9% | -41.6% |
| Free cash flow margin | 0.9% | 1.7% | -3.1% | -0.4% | -6.0% | -1.7% | -13.5% | -20.0% | -22.0% | -45.1% |
| Return on equity | - | - | - | - | - | -112.3% | -64.6% | -31.1% | - | - |
| Return on assets | -3.0% | -2.3% | -12.7% | -12.0% | -21.3% | -15.1% | -31.0% | -24.6% | -32.6% | - |
| Current ratio | 1.09 | 1.13 | 1.07 | 1.19 | 1.32 | 1.76 | 1.92 | 4.79 | 3.63 | - |
Source: XBRL data 111 Inc. files with the SEC, latest filing dated Apr 30, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| YI | CN¥12.56B | -12.8% | -CN¥66.39M | -0.5% | $26.2M |
| CVS | $420.61B | +6.7% | $11.07B | 2.6% | $104.02B |
| GRDN | $1.46B | +4.9% | $74.77M | 5.1% | $2.53B |
| PETS | $168.86M | -20.3% | -$29.28M | -17.3% | $26.9M |
| RDGT | $132.16M | +10.2% | -$1.25M | -0.9% | $2.7M |